Advanced Search
Display options
Filter resources
Text Availability
Article type
Publication date
Species
Language
Sex
Age
Showing 997 to 1006 of 1006 entries
Sorted by: Best Match Show Resources per page
Secondary skin involvement in classic Hodgkin lymphoma: Results of an international collaborative cutaneous lymphoma working group study of 25 patients.

Journal of cutaneous pathology

Gru AA, Bacchi CE, Pulitzer M, Bhagat G, Kempf W, Robson A, Plaza JA, Pincus L, Raghavan S, Xu M, Vencato da Silva T, Salavaggione AL, Subtil A, Battistella M.
PMID: 34089205
J Cutan Pathol. 2021 Nov;48(11):1367-1378. doi: 10.1111/cup.14077. Epub 2021 Jul 05.

BACKGROUND: Cutaneous involvement by classic Hodgkin lymphoma (CHL) is an extraordinarily rare phenomenon in the current era. To date, no single large case series of cutaneous involvement by Hodgkin lymphoma has ever been reported in the literature.METHODS: A comprehensive...

Cite
Gru AA, Bacchi CE, Pulitzer M, et al. Secondary skin involvement in classic Hodgkin lymphoma: Results of an international collaborative cutaneous lymphoma working group study of 25 patients. J Cutan Pathol. 2021;48(11):1367-1378doi: 10.1111/cup.14077.
Gru, A. A., Bacchi, C. E., Pulitzer, M., Bhagat, G., Kempf, W., Robson, A., Plaza, J. A., Pincus, L., Raghavan, S., Xu, M., Vencato da Silva, T., Salavaggione, A. L., Subtil, A., & Battistella, M. (2021). Secondary skin involvement in classic Hodgkin lymphoma: Results of an international collaborative cutaneous lymphoma working group study of 25 patients. Journal of cutaneous pathology, 48(11), 1367-1378. https://doi.org/10.1111/cup.14077
Gru, Alejandro A, et al. "Secondary skin involvement in classic Hodgkin lymphoma: Results of an international collaborative cutaneous lymphoma working group study of 25 patients." Journal of cutaneous pathology vol. 48,11 (2021): 1367-1378. doi: https://doi.org/10.1111/cup.14077
Gru AA, Bacchi CE, Pulitzer M, Bhagat G, Kempf W, Robson A, Plaza JA, Pincus L, Raghavan S, Xu M, Vencato da Silva T, Salavaggione AL, Subtil A, Battistella M. Secondary skin involvement in classic Hodgkin lymphoma: Results of an international collaborative cutaneous lymphoma working group study of 25 patients. J Cutan Pathol. 2021 Nov;48(11):1367-1378. doi: 10.1111/cup.14077. Epub 2021 Jul 05. PMID: 34089205.
Copy Download .nbib Format: NLM
SARS-COV-2 SCREENING IN ALLOGENEIC HEMATOPOIETIC STEM CELL DONORS: IMPLICATIONS FOR THE EVALUATION PROCESS AND ELIGIBILITY.

Hematology, transfusion and cell therapy

Crocchiolo R, Alfarano F, Volpato E, Pugliano M, Cuppari I, Mazza AM, Bellio L, Fanti D, Vismara C, Scaglione F, Sacchi N, Pollichieni S, Mele L, Diral E, Grillo G, Rossini S.
PMID: 34901751
Hematol Transfus Cell Ther. 2021 Dec 07; doi: 10.1016/j.htct.2021.09.017. Epub 2021 Dec 07.

INTRODUCTION: Soon after the onset of the SARS-CoV-2 pandemic, viral screening by nasopharyngeal swab became mandatory for allogeneic hematopoietic stem cell (HSC) donor eligibility.METHODS: We described our monocenter experience with allogeneic HSC donors from February 1 to the October...

Cite
Crocchiolo R, Alfarano F, Volpato E, et al. SARS-COV-2 SCREENING IN ALLOGENEIC HEMATOPOIETIC STEM CELL DONORS: IMPLICATIONS FOR THE EVALUATION PROCESS AND ELIGIBILITY. Hematol Transfus Cell Ther. 2021;doi: 10.1016/j.htct.2021.09.017.
Crocchiolo, R., Alfarano, F., Volpato, E., Pugliano, M., Cuppari, I., Mazza, A. M., Bellio, L., Fanti, D., Vismara, C., Scaglione, F., Sacchi, N., Pollichieni, S., Mele, L., Diral, E., Grillo, G., & Rossini, S. (2021). SARS-COV-2 SCREENING IN ALLOGENEIC HEMATOPOIETIC STEM CELL DONORS: IMPLICATIONS FOR THE EVALUATION PROCESS AND ELIGIBILITY. Hematology, transfusion and cell therapy, . https://doi.org/10.1016/j.htct.2021.09.017
Crocchiolo, Roberto, et al. "SARS-COV-2 SCREENING IN ALLOGENEIC HEMATOPOIETIC STEM CELL DONORS: IMPLICATIONS FOR THE EVALUATION PROCESS AND ELIGIBILITY." Hematology, transfusion and cell therapy vol. (2021). doi: https://doi.org/10.1016/j.htct.2021.09.017
Crocchiolo R, Alfarano F, Volpato E, Pugliano M, Cuppari I, Mazza AM, Bellio L, Fanti D, Vismara C, Scaglione F, Sacchi N, Pollichieni S, Mele L, Diral E, Grillo G, Rossini S. SARS-COV-2 SCREENING IN ALLOGENEIC HEMATOPOIETIC STEM CELL DONORS: IMPLICATIONS FOR THE EVALUATION PROCESS AND ELIGIBILITY. Hematol Transfus Cell Ther. 2021 Dec 07; doi: 10.1016/j.htct.2021.09.017. Epub 2021 Dec 07. PMID: 34901751; PMCID: PMC8648663.
Copy Download .nbib Format: NLM
Population Genomics of Wall Lizards Reflects the Dynamic History of the Mediterranean Basin.

Molecular biology and evolution

Yang W, Feiner N, Salvi D, Laakkonen H, Jablonski D, Pinho C, Carretero MA, Sacchi R, Zuffi MAL, Scali S, Plavos K, Pafilis P, Poulakakis N, Lymberakis P, Jandzik D, Schulte U, Aubret F, Badiane A, Perez I de Lanuza G, Abalos J, While GM, Uller T.
PMID: 34718699
Mol Biol Evol. 2022 Jan 07;39(1). doi: 10.1093/molbev/msab311.

The Mediterranean Basin has experienced extensive change in geology and climate over the past six million years. Yet, the relative importance of key geological events for the distribution and genetic structure of the Mediterranean fauna remains poorly understood. Here,...

Cite
Yang W, Feiner N, Salvi D, et al. Population Genomics of Wall Lizards Reflects the Dynamic History of the Mediterranean Basin. Mol Biol Evol. 2022;39(1)doi: 10.1093/molbev/msab311.
Yang, W., Feiner, N., Salvi, D., Laakkonen, H., Jablonski, D., Pinho, C., Carretero, M. A., Sacchi, R., Zuffi, M. A. L., Scali, S., Plavos, K., Pafilis, P., Poulakakis, N., Lymberakis, P., Jandzik, D., Schulte, U., Aubret, F., Badiane, A., Perez I de Lanuza, G., Abalos, J., While, G. M., & Uller, T. (2022). Population Genomics of Wall Lizards Reflects the Dynamic History of the Mediterranean Basin. Molecular biology and evolution, 39(1), . https://doi.org/10.1093/molbev/msab311
Yang, Weizhao, et al. "Population Genomics of Wall Lizards Reflects the Dynamic History of the Mediterranean Basin." Molecular biology and evolution vol. 39,1 (2022). doi: https://doi.org/10.1093/molbev/msab311
Yang W, Feiner N, Salvi D, Laakkonen H, Jablonski D, Pinho C, Carretero MA, Sacchi R, Zuffi MAL, Scali S, Plavos K, Pafilis P, Poulakakis N, Lymberakis P, Jandzik D, Schulte U, Aubret F, Badiane A, Perez I de Lanuza G, Abalos J, While GM, Uller T. Population Genomics of Wall Lizards Reflects the Dynamic History of the Mediterranean Basin. Mol Biol Evol. 2022 Jan 07;39(1). doi: 10.1093/molbev/msab311. PMID: 34718699.
Copy Download .nbib Format: NLM
Laparoscopic surgery for recurrent Crohn's disease.

Gastroenterology research and practice

Spinelli A, Sacchi M, Bazzi P, Leone N, Danese S, Montorsi M.
PMID: 22253619
Gastroenterol Res Pract. 2012;2012:381017. doi: 10.1155/2012/381017. Epub 2012 Jan 02.

In spite of the recent improvements in drug therapy, surgery still represents the most frequent treatment for Crohn's disease (CD) complications. Laparoscopy has been widely applied over the last twenty years in colorectal surgery and was associated with lower...

Cite
Spinelli A, Sacchi M, Bazzi P, et al. Laparoscopic surgery for recurrent Crohn's disease. Gastroenterol Res Pract. 2012;2012:381017doi: 10.1155/2012/381017.
Spinelli, A., Sacchi, M., Bazzi, P., Leone, N., Danese, S., & Montorsi, M. (2012). Laparoscopic surgery for recurrent Crohn's disease. Gastroenterology research and practice, 2012381017. https://doi.org/10.1155/2012/381017
Spinelli, Antonino, et al. "Laparoscopic surgery for recurrent Crohn's disease." Gastroenterology research and practice vol. 2012 (2012): 381017. doi: https://doi.org/10.1155/2012/381017
Spinelli A, Sacchi M, Bazzi P, Leone N, Danese S, Montorsi M. Laparoscopic surgery for recurrent Crohn's disease. Gastroenterol Res Pract. 2012;2012:381017. doi: 10.1155/2012/381017. Epub 2012 Jan 02. PMID: 22253619; PMCID: PMC3255167.
Copy Download .nbib Format: NLM
Predictors of poor seroconversion and adverse events to SARS-CoV-2 mRNA BNT162b2 vaccine in cancer patients on active treatment.

European journal of cancer (Oxford, England : 1990)

Buttiron Webber T, Provinciali N, Musso M, Ugolini M, Boitano M, Clavarezza M, D'Amico M, Defferrari C, Gozza A, Briata IM, Magnani M, Paciolla F, Menghini N, Marcenaro E, De Palma R, Sacchi N, Innocenti L, Siri G, D'Ecclesiis O, Cevasco I, Gandini S, DeCensi A.
PMID: 34742157
Eur J Cancer. 2021 Dec;159:105-112. doi: 10.1016/j.ejca.2021.09.030. Epub 2021 Oct 11.

PURPOSE: Initial findings in patients with cancer suggest a lower seroconversion to SARS-CoV-2 vaccination possibly related to myelo-immunosuppressive therapies. We conducted a prospective study to assess factors predicting poor seroconversion and adverse events following immunisation (AEFI) to the BNT162b2...

Cite
Buttiron Webber T, Provinciali N, Musso M, et al. Predictors of poor seroconversion and adverse events to SARS-CoV-2 mRNA BNT162b2 vaccine in cancer patients on active treatment. Eur J Cancer. 2021;159:105-112doi: 10.1016/j.ejca.2021.09.030.
Buttiron Webber, T., Provinciali, N., Musso, M., Ugolini, M., Boitano, M., Clavarezza, M., D'Amico, M., Defferrari, C., Gozza, A., Briata, I. M., Magnani, M., Paciolla, F., Menghini, N., Marcenaro, E., De Palma, R., Sacchi, N., Innocenti, L., Siri, G., D'Ecclesiis, O., Cevasco, I., Gandini, S., & DeCensi, A. (2021). Predictors of poor seroconversion and adverse events to SARS-CoV-2 mRNA BNT162b2 vaccine in cancer patients on active treatment. European journal of cancer (Oxford, England : 1990), 159105-112. https://doi.org/10.1016/j.ejca.2021.09.030
Buttiron Webber, Tania, et al. "Predictors of poor seroconversion and adverse events to SARS-CoV-2 mRNA BNT162b2 vaccine in cancer patients on active treatment." European journal of cancer (Oxford, England : 1990) vol. 159 (2021): 105-112. doi: https://doi.org/10.1016/j.ejca.2021.09.030
Buttiron Webber T, Provinciali N, Musso M, Ugolini M, Boitano M, Clavarezza M, D'Amico M, Defferrari C, Gozza A, Briata IM, Magnani M, Paciolla F, Menghini N, Marcenaro E, De Palma R, Sacchi N, Innocenti L, Siri G, D'Ecclesiis O, Cevasco I, Gandini S, DeCensi A. Predictors of poor seroconversion and adverse events to SARS-CoV-2 mRNA BNT162b2 vaccine in cancer patients on active treatment. Eur J Cancer. 2021 Dec;159:105-112. doi: 10.1016/j.ejca.2021.09.030. Epub 2021 Oct 11. PMID: 34742157; PMCID: PMC8502731.
Copy Download .nbib Format: NLM
Governance and groundwater modelling: Hints to boost the implementation of the EU Nitrate Directive. The Lombardy Plain case, N Italy.

The Science of the total environment

Musacchio A, Mas-Pla J, Soana E, Re V, Sacchi E.
PMID: 33838379
Sci Total Environ. 2021 Aug 15;782:146800. doi: 10.1016/j.scitotenv.2021.146800. Epub 2021 Mar 27.

The EU Nitrate Directive has been ruling for almost 30 years, nevertheless nitrate concentration in the Lombardy Plain did not decrease. Together with failures of management implementation, a possible cause for such field observations is that management actions were...

Cite
Musacchio A, Mas-Pla J, Soana E, et al. Governance and groundwater modelling: Hints to boost the implementation of the EU Nitrate Directive. The Lombardy Plain case, N Italy. Sci Total Environ. 2021;782:146800doi: 10.1016/j.scitotenv.2021.146800.
Musacchio, A., Mas-Pla, J., Soana, E., Re, V., & Sacchi, E. (2021). Governance and groundwater modelling: Hints to boost the implementation of the EU Nitrate Directive. The Lombardy Plain case, N Italy. The Science of the total environment, 782146800. https://doi.org/10.1016/j.scitotenv.2021.146800
Musacchio, Arianna, et al. "Governance and groundwater modelling: Hints to boost the implementation of the EU Nitrate Directive. The Lombardy Plain case, N Italy." The Science of the total environment vol. 782 (2021): 146800. doi: https://doi.org/10.1016/j.scitotenv.2021.146800
Musacchio A, Mas-Pla J, Soana E, Re V, Sacchi E. Governance and groundwater modelling: Hints to boost the implementation of the EU Nitrate Directive. The Lombardy Plain case, N Italy. Sci Total Environ. 2021 Aug 15;782:146800. doi: 10.1016/j.scitotenv.2021.146800. Epub 2021 Mar 27. PMID: 33838379.
Copy Download .nbib Format: NLM
Analysis of Feasibility, Adherence, and Appreciation of a Newly Developed Tele-Rehabilitation Program for People With MCI and VCI.

Frontiers in neurology

Mosca IE, Salvadori E, Gerli F, Fabbri L, Pancani S, Lucidi G, Lombardi G, Bocchi L, Pazzi S, Baglio F, Vannetti F, Sorbi S, Macchi C.
PMID: 33329326
Front Neurol. 2020 Nov 27;11:583368. doi: 10.3389/fneur.2020.583368. eCollection 2020.

No abstract available.

Cite
Mosca IE, Salvadori E, Gerli F, et al. Analysis of Feasibility, Adherence, and Appreciation of a Newly Developed Tele-Rehabilitation Program for People With MCI and VCI. Front Neurol. 2020;11:583368doi: 10.3389/fneur.2020.583368.
Mosca, I. E., Salvadori, E., Gerli, F., Fabbri, L., Pancani, S., Lucidi, G., Lombardi, G., Bocchi, L., Pazzi, S., Baglio, F., Vannetti, F., Sorbi, S., & Macchi, C. (2020). Analysis of Feasibility, Adherence, and Appreciation of a Newly Developed Tele-Rehabilitation Program for People With MCI and VCI. Frontiers in neurology, 11583368. https://doi.org/10.3389/fneur.2020.583368
Mosca, Irene Eleonora, et al. "Analysis of Feasibility, Adherence, and Appreciation of a Newly Developed Tele-Rehabilitation Program for People With MCI and VCI." Frontiers in neurology vol. 11 (2020): 583368. doi: https://doi.org/10.3389/fneur.2020.583368
Mosca IE, Salvadori E, Gerli F, Fabbri L, Pancani S, Lucidi G, Lombardi G, Bocchi L, Pazzi S, Baglio F, Vannetti F, Sorbi S, Macchi C. Analysis of Feasibility, Adherence, and Appreciation of a Newly Developed Tele-Rehabilitation Program for People With MCI and VCI. Front Neurol. 2020 Nov 27;11:583368. doi: 10.3389/fneur.2020.583368. eCollection 2020. PMID: 33329326; PMCID: PMC7728852.
Copy Download .nbib Format: NLM
GITMO Registry Study of Allogeneic Transplantation in Patients Age >60 Years, 2000 to 2017: Improvements and Criticisms.

Transplantation and cellular therapy

Malagola M, Polverelli N, Rubini V, Martino M, Patriarca F, Bruno B, Giaccone L, Grillo G, Bramanti S, Bernasconi P, De Gobbi M, Natale A, Terruzzi E, Olivieri A, Chiusolo P, Carella AM, Casini M, Nozzoli C, Mazza P, Bassi S, Onida F, Vacca A, Falcioni S, Luppi M, Iori AP, Pavone V, Skert C, Carluccio P, Borghero C, Proia A, Selleri C, Sacchi N, Mammoliti S, Oldani E, Ciceri F, Russo D, Bonifazi F.
PMID: 34818581
Transplant Cell Ther. 2021 Nov 21; doi: 10.1016/j.jtct.2021.11.006. Epub 2021 Nov 21.

Today, allogeneic stem cell transplantation (allo-SCT) can be offered to patients up to age 70 to 72 years and represents one of the most effective curative treatments for many hematologic malignancies. The primary objective of the study was to...

Cite
Malagola M, Polverelli N, Rubini V, et al. GITMO Registry Study of Allogeneic Transplantation in Patients Age >60 Years, 2000 to 2017: Improvements and Criticisms. Transplant Cell Ther. 2021;doi: 10.1016/j.jtct.2021.11.006.
Malagola, M., Polverelli, N., Rubini, V., Martino, M., Patriarca, F., Bruno, B., Giaccone, L., Grillo, G., Bramanti, S., Bernasconi, P., De Gobbi, M., Natale, A., Terruzzi, E., Olivieri, A., Chiusolo, P., Carella, A. M., Casini, M., Nozzoli, C., Mazza, P., Bassi, S., Onida, F., Vacca, A., Falcioni, S., Luppi, M., Iori, A. P., Pavone, V., Skert, C., Carluccio, P., Borghero, C., Proia, A., Selleri, C., Sacchi, N., Mammoliti, S., Oldani, E., Ciceri, F., Russo, D., & Bonifazi, F. (2021). GITMO Registry Study of Allogeneic Transplantation in Patients Age >60 Years, 2000 to 2017: Improvements and Criticisms. Transplantation and cellular therapy, . https://doi.org/10.1016/j.jtct.2021.11.006
Malagola, Michele, et al. "GITMO Registry Study of Allogeneic Transplantation in Patients Age >60 Years, 2000 to 2017: Improvements and Criticisms." Transplantation and cellular therapy vol. (2021). doi: https://doi.org/10.1016/j.jtct.2021.11.006
Malagola M, Polverelli N, Rubini V, Martino M, Patriarca F, Bruno B, Giaccone L, Grillo G, Bramanti S, Bernasconi P, De Gobbi M, Natale A, Terruzzi E, Olivieri A, Chiusolo P, Carella AM, Casini M, Nozzoli C, Mazza P, Bassi S, Onida F, Vacca A, Falcioni S, Luppi M, Iori AP, Pavone V, Skert C, Carluccio P, Borghero C, Proia A, Selleri C, Sacchi N, Mammoliti S, Oldani E, Ciceri F, Russo D, Bonifazi F. GITMO Registry Study of Allogeneic Transplantation in Patients Age >60 Years, 2000 to 2017: Improvements and Criticisms. Transplant Cell Ther. 2021 Nov 21; doi: 10.1016/j.jtct.2021.11.006. Epub 2021 Nov 21. PMID: 34818581.
Copy Download .nbib Format: NLM
Surgically treated mediastinal fat necrosis: an exception to conservative treatment.

Indian journal of thoracic and cardiovascular surgery

Moreira BL, Chaves HL, Santana PRP, de Araújo NT, Imaeda CJ, da Silveira NSS, Bacchi CE, Marchiori E.
PMID: 34511769
Indian J Thorac Cardiovasc Surg. 2021 Sep;37(5):581-583. doi: 10.1007/s12055-021-01149-6. Epub 2021 Mar 02.

Mediastinal fat necrosis is an important differential diagnosis for acute chest pain in previously healthy patients. Imaging examination is essential to establish this diagnosis, as physical examination can be unhelpful and laboratory tests are non-specific. The treatment of choice...

Cite
Moreira BL, Chaves HL, Santana PRP, et al. Surgically treated mediastinal fat necrosis: an exception to conservative treatment. Indian J Thorac Cardiovasc Surg. 2021;37(5):581-583doi: 10.1007/s12055-021-01149-6.
Moreira, B. L., Chaves, H. L., Santana, P. R. P., de Araújo, N. T., Imaeda, C. J., da Silveira, N. S. S., Bacchi, C. E., & Marchiori, E. (2021). Surgically treated mediastinal fat necrosis: an exception to conservative treatment. Indian journal of thoracic and cardiovascular surgery, 37(5), 581-583. https://doi.org/10.1007/s12055-021-01149-6
Moreira, Bruno Lima, et al. "Surgically treated mediastinal fat necrosis: an exception to conservative treatment." Indian journal of thoracic and cardiovascular surgery vol. 37,5 (2021): 581-583. doi: https://doi.org/10.1007/s12055-021-01149-6
Moreira BL, Chaves HL, Santana PRP, de Araújo NT, Imaeda CJ, da Silveira NSS, Bacchi CE, Marchiori E. Surgically treated mediastinal fat necrosis: an exception to conservative treatment. Indian J Thorac Cardiovasc Surg. 2021 Sep;37(5):581-583. doi: 10.1007/s12055-021-01149-6. Epub 2021 Mar 02. PMID: 34511769; PMCID: PMC8387518.
Copy Download .nbib Format: NLM
Negative-pressure wound therapy after stoma reversal in colorectal surgery: a randomized controlled trial.

BJS open

Carrano FM, Maroli A, Carvello M, Foppa C, Sacchi M, Crippa J, Clerico G, De Lucia F, Coppola E, Ben David N, Spinelli A.
PMID: 34904647
BJS Open. 2021 Nov 09;5(6). doi: 10.1093/bjsopen/zrab116.

BACKGROUND: Stoma-reversal surgery is associated with high postoperative morbidity, including wound complications and surgical-site infections (SSIs). This study aims to assess whether the application of negative-pressure wound therapy (NPWT) can improve wound healing compared with conventional wound dressing.METHODS: This...

Cite
Carrano FM, Maroli A, Carvello M, et al. Negative-pressure wound therapy after stoma reversal in colorectal surgery: a randomized controlled trial. BJS Open. 2021;5(6)doi: 10.1093/bjsopen/zrab116.
Carrano, F. M., Maroli, A., Carvello, M., Foppa, C., Sacchi, M., Crippa, J., Clerico, G., De Lucia, F., Coppola, E., Ben David, N., & Spinelli, A. (2021). Negative-pressure wound therapy after stoma reversal in colorectal surgery: a randomized controlled trial. BJS open, 5(6), . https://doi.org/10.1093/bjsopen/zrab116
Carrano, Francesco M, et al. "Negative-pressure wound therapy after stoma reversal in colorectal surgery: a randomized controlled trial." BJS open vol. 5,6 (2021). doi: https://doi.org/10.1093/bjsopen/zrab116
Carrano FM, Maroli A, Carvello M, Foppa C, Sacchi M, Crippa J, Clerico G, De Lucia F, Coppola E, Ben David N, Spinelli A. Negative-pressure wound therapy after stoma reversal in colorectal surgery: a randomized controlled trial. BJS Open. 2021 Nov 09;5(6). doi: 10.1093/bjsopen/zrab116. PMID: 34904647.
Copy Download .nbib Format: NLM
Showing 997 to 1006 of 1006 entries